Evgeni Grigorov | Pharmacovigilance | OncologyPharmaOnc Trailblazer Award

Published on by Top Pharmaceutical
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 2636

Register Here

Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Muhammad Musa Khan | Drug Safety and Risk Management | Best Researcher Award

Associate Researcher at Hainan Institute of Zhejiang University | China

Dr. Muhammad Musa Khan is a Pakistani entomologist and research scientist with an extensive background in agricultural entomology, insect toxicology, and pest management. Currently serving as an Associate Researcher at the Hainan Institute of Zhejiang University, China, he focuses on pesticide toxicity, ecological risk assessment, and resistance management in agroecosystems. His research spans ecological, molecular, and toxicological approaches to pest control. Dr. Khan has published prolifically in high-impact journals and is recognized for advancing sustainable pest management strategies. His collaborative, multidisciplinary work integrates field ecology with molecular diagnostics, benefiting both science and agriculture on a global scale.

Publication Profile 

Google Scholar

Education 

Dr. Khan earned his Ph.D. in Agricultural Entomology and Pest Control from Huazhong Agricultural University, China, where he worked on predator safety in rice ecosystems. He completed his M.Sc. (Hons) in Entomology from the University of Agriculture Faisalabad, Pakistan, researching resistance mechanisms in cotton against sap-sucking pests. His undergraduate degree (B.Sc. Hons) in Agriculture with a specialization in Entomology was obtained from PMAS Arid Agriculture University, Rawalpindi. Additionally, he interned at the Nuclear Institute for Agriculture and Biology, gaining hands-on expertise in biological control agent rearing and field application methods.

Experience 

Dr. Khan currently serves as Associate Researcher at the Hainan Institute of Zhejiang University, China, investigating pesticide toxicity and resistance in brown planthopper and rice ecosystems. His previous role as a Postdoctoral Researcher at South China Agricultural University involved studying the effects of UV light on whiteflies and moths. During his Ph.D., he explored ecotoxicological risks of insecticides on beneficial insects and tested essential oil-based pest repellent strategies. His scientific skillset encompasses molecular biology techniques, gene expression analysis, bioinformatics, and biostatistics. His interdisciplinary approach allows integration of molecular diagnostics with field-level pest management.

Awards and Honors 

Dr. Khan has received significant recognition for his impactful research, including editorial contributions to international journals such as Frontiers in Plant Science. His publications have consistently appeared in top-tier Q1 journals like Journal of Hazardous Materials and Chemosphere. As a corresponding author and equal first author, his contributions are well-acknowledged in international collaborations. His work has received citations and global visibility for its originality in ecological toxicology and entomological innovation. Moreover, his involvement in multiple Chinese institutions and his role in international research networks reflect his growing influence and leadership in the agricultural research community.

Research Focus 

Dr. Khan’s research bridges entomology, toxicology, and molecular biology with a primary focus on insecticide resistance, non-target toxicity, and ecological safety in agroecosystems. He specializes in assessing chemical and environmental stressors on pests and their natural enemies, especially in rice and vegetable production systems. His studies utilize DNA/RNA techniques, gene expression profiling, and biochemical assays to decipher the molecular impact of pesticides and ultraviolet exposure on pest physiology and behavior. He is particularly interested in predator-prey dynamics, pollinator safety, integrated pest management, and sustainable solutions to enhance agricultural productivity while minimizing ecological harm.

Publication Top Notes

Role of insect gut microbiota in pesticide degradation: a review

Metabolic-based insecticide resistance mechanism and ecofriendly approaches for controlling of beet armyworm Spodoptera exigua: a review

Impact of invasive ant species on native fauna across similar habitats under global environmental changes

Lethal and sublethal effects of emamectin benzoate on the rove beetle, Paederus fuscipes, a non-target predator of rice brown planthopper, Nilaparvata lugens

Identification of attractants from plant essential oils for Cyrtorhinus lividipennis, an important predator of rice planthoppers

Role of digestive protease enzymes and related genes in host plant adaptation of a polyphagous pest, Spodoptera frugiperda

Temperature-Dependent Functional Response of Harmonia axyridis (Coleoptera: Coccinellidae) on the Eggs of Spodoptera litura (Lepidoptera: Noctuidae) in …

Lethal and Sublethal Effects of Chlorpyrifos on Biological Traits and Feeding of the Aphidophagous Predator Harmonia axyridis

Sublethal effects of chlorantraniliprole on Paederus fuscipes (Staphylinidae: Coleoptera), a general predator in paddle field

Using a Two-Sex Life Table Tool to Calculate the Fitness of Orius strigicollis as a Predator of Pectinophora gossypiella

Insecticide resistance and detoxification enzymes activity in Nilaparvata lugens Stål against neonicotinoids

Emamectin benzoate induced enzymatic and transcriptional alternation in detoxification mechanism of predatory beetle Paederus fuscipes (Coleoptera: Staphylinidae) at the …

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

Published on by Top Pharmaceutical

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

Dr. luis Guerra Sánchez, HGU Gregorio Marañon, Spain

Dr. Luis Guerra Sánchez is an esteemed Spanish nurse and researcher with a Ph.D. in Nursing Care Research 🎓 from Universidad Complutense de Madrid. With degrees in Nursing (Graduate & Diploma) 🏥 and a Master’s in Nursing Research, his academic journey reflects excellence and dedication. He has completed over 40 advanced professional trainings 🧠, specializing in chronic care, diabetes, neonatal intensive care, statistics, leadership, and biomedical research 📊🧪. Dr. Sánchez is deeply committed to healthcare innovation, evidence-based practice, and continuous learning, making significant contributions to nursing education and clinical practice. A true advocate for patient-centered care and professional growth.

Publication Profile 

Orcid

Education

Dr. Luis Guerra Sánchez holds a robust academic foundation in nursing, highlighted by a Ph.D. in Investigación en Cuidados de Enfermería 🎓 and a Master’s degree in Investigación en Cuidados from Universidad Complutense de Madrid 🏛️. His commitment to lifelong learning is evident in his completion of over 40 specialized training programs, covering diverse areas such as chronic patient care, diabetes management, neonatal intensive care, biomedical research, statistics, and healthcare leadership 📊🧪💉. With extensive experience in clinical and academic settings, Dr. Sánchez continues to contribute meaningfully to healthcare excellence and nursing advancement across Spain and beyond.

Awards

Dr. Luis Guerra Sánchez has pursued extensive professional development through a wide array of training programs and certifications 🎓. His credentials include courses in research methodology 🧪, statistical analysis 📊, and healthcare management 🏥. He holds specialized certifications in critical care 🚑, cardiology ❤️, and neonatology 👶, reflecting his deep commitment to high-level clinical expertise. With over four decades of continuous learning, his qualifications span from advanced clinical practices to leadership and teaching in healthcare. These achievements underline his dedication to excellence and innovation in patient care, nursing education, and evidence-based medical practice.

Experience

Dr. Luis Guerra Sánchez brings a wealth of experience in both clinical practice and scientific research 🏥📚. His professional journey spans diverse healthcare settings, where he has contributed significantly through patient care, management, and academic mentoring 👨‍⚕️👨‍🏫. With numerous certifications and continuous training in specialized areas such as cardiology, neonatology, and chronic disease management ❤️👶, he exemplifies lifelong learning. His involvement in research projects and data-driven healthcare innovations reflects a strong dedication to evidence-based practice and improving patient outcomes 🔎📈. Dr. Sánchez’s impact extends across clinical, educational, and investigative domains, making him a leader in modern nursing.

Research Focus

Dr. Luis Guerra Sánchez’s scholarship sits at the crossroads of clinical nutrition, cardiovascular nursing, and patient‑safety science. His randomized trials explore how tailored dietary strategies can reverse malnutrition, boost functional capacity, and elevate quality of life in chronic heart‑failure patients 🫀📈. Parallel work standardises intravenous therapies and analgesia–sedation practices in ICUs, tightening medication‑safety protocols 💉🔒. Through multicentre audits, he spotlights delirium, restraint use, and nutritional risk—generating evidence for nurse‑led interventions that cut complications and hospital days 🏥⏱️. Overall, Luis champions evidence‑based, nurse‑driven care models that fuse nutrition science with cardiology and critical‑care best practices, improving outcomes across vulnerable populations .

Publication Top Notes

  • Effect of a double nutritional intervention on the nutritional status, functional capacity, and quality of life of patients with chronic heart failure: 12-month results from a randomized clinical trial
  • Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety.
  • Assessment of analgesia, sedation, physical restraint and delirium in patients admitted to Spanish intensive care units. Proyecto ASCyD
  • Nutritional intervention in patients with heart failure. 3 month results of a clinical trial
  • [Prevalence of undernutrition in hospital patients with unbalanced heart failure; subjective global assessment like prognosis sign].

  • [Nutritional screening in heart failure patients: 5 methods review].

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dhanpat Sharma | Drug Safety and Risk Management | Best Researcher Award

Dr. Dhanpat Sharma, Central University of Haryana, India

Dr. Dhanpat Sharma is a passionate physicist who recently submitted his Ph.D. thesis at the Central University of Haryana, India, focusing on the generation of magnetic fields during heavy ion collisions. His work bridges theoretical simulations with experimental studies involving low-intensity magnetic fields for environmental applications. He has published extensively on photocatalysis, nanomaterials, and nuclear physics. Dr. Sharma is a recipient of multiple prestigious fellowships, including UGC-CSIR NET-JRF and GATE, and has actively presented his research at national and international conferences. His innovative insights continue to contribute significantly to nuclear and materials science.

Publication Profile

orcid

Education

Dr. Dhanpat Sharma 🎓 is a dedicated physicist currently pursuing his Ph.D. in Physics at the Central University of Haryana, Mahendergarh, India, from August 2019 to April 2025. His research, guided by Prof. Suneel Kumar, focuses on the study of nuclear flow, nuclear stopping, magnetic fields, and their inter-correlations in heavy ion collisions ⚛️. He earned his M.Sc. in Physics from Maharishi Dayanand University, Rohtak, between 2016 and 2018 📘. Prior to that, he completed his B.Sc. in Physics, Chemistry, and Mathematics at Kirori Mal College, University of Delhi 🎓, from 2012 to 2016, laying a strong foundation for his scientific journey.

Experience

Dr. Dhanpat Sharma 💻 has hands-on experience in coding within the Quantum Molecular Dynamics (QMD) and Isospin-dependent Quantum Molecular Dynamics (IQMD) frameworks, which are essential tools for simulating heavy ion collisions at intermediate energies ⚛️. His work involves implementing and modifying simulation codes to analyze nuclear flow, nuclear stopping, and magnetic field effects. Through this expertise, Dr. Sharma has gained a deep understanding of the computational modeling of complex nuclear interactions 🧠. His coding proficiency allows him to conduct high-level theoretical research, contributing significantly to the field of nuclear physics 🔬, and enhancing predictive accuracy in nuclear collision studies.

Awards

Dr. Dhanpat Sharma 🏅 has been recognized for his academic excellence with several prestigious awards and honors. He qualified the UGC-CSIR NET-JRF twice, in December 2018 and July 2019, earning a fellowship for his Ph.D. studies 🎓. Additionally, he cleared the GATE exam in February 2019, further showcasing his strong command in physics 📘. Dr. Sharma also qualified for the IGCAR entrance with an impressive All India Rank of 34 🔬. Demonstrating consistent academic merit, he secured the 4th rank in the Ph.D. entrance test conducted by the University of Delhi, solidifying his position among top research scholars in India 🇮🇳.

Research Focus

Dr. Dhanpat Sharma focuses on magneto-photocatalysis, heavy-ion collision physics, and advanced nanomaterials for energy and environmental applications. His research spans the development of photocatalytic materials like α-γ-Fe₂O₃/rGO for antibiotic degradation 💊, to synthesizing nanocomposites for energy storage ⚡ using waste-derived Fe₃O₄. In nuclear physics, he explores the evolution of magnetic and electromagnetic fields 🧲 during heavy-ion collisions, studying correlations with nuclear stopping and elliptical flow. His interdisciplinary expertise bridges materials science, nuclear theory, and applied nanotechnology 🧪, addressing both sustainable tech and fundamental particle interactions in extreme conditions.

Publication Top Notes

Magnetic field and dissolved oxygen assisted ultra-high photocatalytic activity of α-γ-Fe2O3 heterophase wrapped with rGO sheets for the removal of rifampicin

Waste toner derived Fe3O4 nanoparticles embedment into PANI matrix as an advanced electrode for supercapacitor

Probing the contribution of various mass fragments in the production of magnetic field during heavy ion collisions

Correlation between elliptical flow and nuclear stopping around the transition energy in mid rapidity zone

Influence of symmetry energy on electromagnetic field during heavy-ion collisions
Correlation between magnetic field and nuclear stopping in different rapidity segments during heavy ion collisions
Production of magnetic field due to heavy ion collisions around transition energy

Roxana Matran | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Roxana Matran | Pharmacology | Best Researcher Award

Assist Prof Dr Roxana Matran, UMF “Carol Davila”, Romania

Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic with a Ph.D. from Carol Davila University of Medicine and Pharmacy (2017) 🎓. An Assistant Professor at the same university since 2019, she excels in teaching and research on pediatric pulmonology and gastroenterology. Her clinical expertise at “Grigore Alexandrescu” Emergency Hospital for Children includes contributions to groundbreaking clinical trials on inflammatory bowel diseases 🏥🔬. A dedicated volunteer with MD Caravana cu Medici 🤝, she brings healthcare to underserved communities. Dr. Matran’s active membership in ESPGHAN and advisory roles showcase her impactful influence in public health policy 🌍✨.

Publication Profile

orcid

Educational Backgrounds

Assist. Prof. Dr. Roxana Matran embarked on her academic journey at the prestigious Central School in Bucharest, where she specialized in Mathematics-Informatics with bilingual French instruction (📘✏️). She continued her education at “Carol Davila” University of Medicine and Pharmacy, earning a Bachelor’s Degree in 2009 (🎓🩺). Driven by her passion for medicine, she pursued a Ph.D. at the same university, completing her thesis on factors contributing to pulmonary disease in cystic fibrosis between 2013 and 2017 (📄🫁). Her dedication and expertise in the medical field have solidified her reputation as a leading academic and researcher in Bucharest (🌟🏥).

Work Experiance

Assist. Prof. Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic based in Bucharest. She serves as a member of the Advisory Committee on Post-Vaccination Adverse Reactions, analyzing vaccine-related health concerns (💉📊). She is also a sub-investigator in pivotal clinical trials, including studies on Vedolizumab and Adalimumab for pediatric Crohn’s disease and ulcerative colitis (🔬📑). Dr. Matran volunteers with Caravana cu Medici, offering medical consultations in underserved Romanian villages (🚑🤝). As an Assistant Professor at “Carol Davila” University, she teaches fifth-year medical students and conducts extensive research (📚👩‍🔬). Her work at “Grigore Alexandrescu” Emergency Hospital focuses on consultations, rounds, and clinical studies (🏥👶).

Membership

Assist. Prof. Dr. Roxana Matran is an active member of esteemed professional organizations in her field. Since June 2019, she has been a Full Member of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN), contributing to advancements in pediatric healthcare across Europe (🌍👶🩺). Additionally, she has been a dedicated member of the Romanian Society of Pediatrics since July 2016, working to promote excellence in pediatric medicine and research in her home country (🇷🇴📚💉). Her involvement in these societies underscores her commitment to improving children’s health and staying at the forefront of medical advancements (🌟🔬).

Conference and Seminars

Assist. Prof. Dr. Roxana Matran has an extensive track record of participation in prestigious medical events and specialized training programs worldwide. In 2024, she is set to attend the 5th Liver Transplant School in Brussels (25–28 September) and the ESPGHAN Mastercourse in Parenteral Nutrition in Linz, Austria (4–6 March). Her prior engagements include the ESPGHAN IBD Masterclass in Helsinki, Finland (2022) and the International Symposium on Pediatric Inflammatory Bowel Disease in Edinburgh, Scotland (2022). Over the years, she has honed her expertise in pediatric gastroenterology, nutrition, and pulmonology, attending courses in Italy 🇮🇹, Austria 🇦🇹, France 🇫🇷, and Greece 🇬🇷, and even completing a post-graduate program online 🌐.

Community Impact

Assist. Prof. Dr. Roxana Matran is deeply committed to serving underserved communities, demonstrating her passion for equitable healthcare access. She actively volunteers with MD Caravana cu Medici, a noble initiative providing essential medical consultations in impoverished Romanian villages 🏡. Through this work, Dr. Matran brings her expertise in pediatric gastroenterology and nutrition to those who need it most, offering care, guidance, and hope 🌟. Her dedication to improving public health goes beyond the clinic, reflecting a strong sense of compassion and responsibility toward marginalized populations 🤝. Dr. Matran’s efforts exemplify the true spirit of community service and medical care ❤️.

Clinical Expertise

Assist. Prof. Dr. Roxana Matran has made significant contributions to pediatric gastroenterology through her clinical practice, research, and involvement in clinical trials. As a pediatric gastroenterologist at “Grigore Alexandrescu” Emergency Hospital for Children 🏥, she seamlessly combines patient care with groundbreaking research. Dr. Matran has actively contributed as a subinvestigator for leading pharmaceutical companies, including Takeda Pharmaceuticals (VedolizumabSC-3003) and AbbVie (Adalimumab), advancing therapies for pediatric inflammatory bowel disease 🔬. She also researches post-vaccination adverse reactions as a member of the Advisory Committee at the Ministry of Health, ensuring better health outcomes for children globally 💉.

Research Focus

Dr. Roxana Elena Smădeanu’s research focus primarily revolves around pediatric health, with a special emphasis on diagnosing and managing complex diseases such as cystic fibrosis, intestinal tuberculosis, and respiratory conditions in children. Her work includes exploring microbiota’s role in functional abdominal pain disorders, respiratory symptomatology associated with COVID-19 in pediatric patients, and rare genetic syndromes like Menke-Hennekam syndrome. Additionally, her research delves into diagnostic methods like sweat conductivity in cystic fibrosis. This body of work aligns with clinical and laboratory research aimed at improving pediatric healthcare and diagnostics. 🧑‍🔬🩺👶

Publication Top Notes

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center

Food Related Quality of Life in Children with Chronic Gastrointestinal Disorders: Comparative Study Between Inflammatory Bowel Disease and Celiac Disease—Reports from a Romanian Center

Anti TNF-a Use in Pediatric Inflammatory Bowel Disease – Reports from a Romanian Center

Quality of Life of Pediatric Patients with Chronic Intestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic

Menke–Hennekam Syndrome: A Literature Review and a New Case Report

Ms. Tahere Abdollahi |Drug Safety and Risk Management |Women Researcher Award

Published on by Top Pharmaceutical

Ms. Tahere Abdollahi|Drug Safety and Risk Management |Women Researcher Award

Ms. Tahere Abdollahi at Hamadan University of Medical Sciences,Iran

PROFILE  

Orcid

Early Academic Pursuits 🎓

Tahere Abdollahi embarked on her academic journey with a strong foundation in Occupational Health Engineering. She pursued a Master’s degree in this field at Hamadan University of Medical Sciences, which is renowned for producing professionals with expertise in healthcare and occupational safety. Her academic focus on occupational health was driven by a passion for improving workplace environments, particularly in industries dealing with hazardous substances. During her early years as a student, Tahere developed a keen interest in the impact of industrial chemicals and drugs on human health, a theme that would shape her future research.

Her commitment to academic excellence allowed her to gain a comprehensive understanding of the science of occupational health. She was actively involved in laboratory work, field studies, and academic discussions, all of which solidified her knowledge base in the subject. These early academic experiences laid the groundwork for her future endeavors as an occupational health consultant and researcher.

Professional Endeavors 👩‍⚕️

Currently, Tahere Abdollahi holds a significant role as an Occupational Health Consultant in the medical equipment industry. Her expertise allows her to offer critical insights into the health risks associated with medical environments and equipment, ensuring that workers in this sector remain protected from occupational hazards. Her consulting work extends to evaluating the safety of equipment used in healthcare settings, as well as suggesting improvements to reduce potential risks.

In addition to her consulting role, Tahere continues to engage in academic and research activities. Her involvement in ongoing research projects reflects her commitment to advancing the field of occupational health. By focusing on industries with high exposure risks, such as ferrosilicon production and oncology nursing, she highlights the often-overlooked dangers in these environments, contributing to the improvement of workplace health standards.

Contributions and Research Focus 🔬

One of Tahere’s notable research contributions includes a study titled “Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study”, which is indexed in Scopus. This research delved into the oxidative stress faced by nurses who are regularly exposed to antineoplastic drugs, which are commonly used in cancer treatments. The study provided valuable data on the biomarkers associated with oxidative stress in these healthcare workers, emphasizing the need for better protective measures and health monitoring in hospitals and oncology departments.

Her current research focuses on the ferrosilicon industry, where she is studying the impact of chemical exposure on workers’ health. The goal of this study is to identify key biomarkers of oxidative stress and other health concerns that can arise from prolonged exposure to industrial chemicals, with a view to proposing solutions that can mitigate these risks. Through these projects, Tahere has made a significant contribution to both the occupational health and healthcare fields by addressing the unseen risks faced by workers.

Accolades and Recognition 🏆

While still early in her career, Tahere Abdollahi has already gained recognition for her research work, particularly her study on oxidative stress in oncology nurses. This research has been published in a Scopus-indexed journal, an achievement that speaks to the quality and relevance of her work. Her contribution to occupational health through her research is commendable, and her work has the potential to influence safety regulations and practices in healthcare settings.

Tahere has also applied for the Best Researcher Award in the international top pharmaceutical awards, which would serve as a well-deserved recognition for her ongoing dedication and impactful work in the field of occupational health.

Impact and Influence 🌍

The research and professional contributions of Tahere Abdollahi extend beyond academia. Her work on evaluating oxidative stress biomarkers among healthcare professionals has highlighted the potential long-term health risks faced by oncology nurses and other healthcare workers. This has led to a broader discussion in medical circles about improving safety protocols and protective measures for workers exposed to hazardous substances in hospitals and medical settings.

Her influence is also being felt in the industrial sector, where her ongoing research on ferrosilicon industries could lead to substantial improvements in workplace safety standards. By focusing on the health risks associated with chemical exposure, she is helping to drive the development of better monitoring systems and protective measures for workers in high-risk industries.

Legacy and Future Contributions 🌟

As an emerging researcher and consultant, Tahere Abdollahi’s future contributions are poised to have a lasting impact on occupational health, particularly in high-risk industries such as healthcare and chemical manufacturing. Her studies on oxidative stress and chemical exposure have the potential to influence policy changes and lead to more stringent safety regulations, benefiting workers across a wide range of sectors.

Her ongoing research promises to add further depth to her already impressive body of work, with a focus on enhancing worker safety and health in environments where exposure to hazardous substances is common. Tahere is likely to continue collaborating with experts across industries, contributing her knowledge and expertise to safeguard the health of countless workers.

In the years to come, her legacy will likely include being a key advocate for worker safety in occupational health. Her work will not only serve as a blueprint for future researchers but will also drive real-world changes in occupational safety standards.

Conclusion ✨

Tahere Abdollahi is a rising star in the field of occupational health engineering. Her academic and professional background, coupled with her impactful research on healthcare workers and industrial safety, positions her as an influential figure in her field. Through her work, she continues to champion the health and safety of workers, and her ongoing contributions are sure to leave a lasting mark on occupational health practices and policies worldwide.

🎓Publication 

Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study

  • Authors   : Abdollahi, T.; Ranjbar, A.; Faradmal, J.; Mohraz, M.H.; Assari, M.J.
  • Journal    :Oncology Nursing
  • Year         :2024

Mrs .Elena Reshetova, Drug Safety and Risk Management,Best Researcher Award-1150

Published on by Top Pharmaceutical

Mrs .Elena Reshetova,Drug Safety and Risk Management ,Best Researcher Award

 Mrs .Elena Reshetova, at Institute of Technical Chemistry UB RAS,Russia

Author Profile

 

🎓Education:

  • Ph.D. in Physical Chemistry, 2011, Perm State University
    Dissertation: «The regularities of retention and separation of profen enantiomers on chiral stationary phases»
  • M.Sc. in Chemistry, 2006, Perm State University

Research and Innovations:

Elena has led multiple research projects, including:
  1. Retention mechanisms of weak electrolytes in chiral chromatography (Russian Science Foundation, 2023-2024)
  2. Investigation of the adsorption of enantiomers of hydroxy acids and their derivatives on chiral stationary phases (RFBR, 2018-2020)
  3. The regularities of enantioselective adsorption of drugs on chiral stationary phases of different chemical nature (RFBR, 2015-2017)
  4. Adsorption of enantiomers of biologically active compounds on chiral stationary phases under high-performance liquid chromatography conditions (Grant of the President of RF, 2013-2014)
  5. Development of high performance liquid chromatography and capillary electrophoresis methods for resolution and analysis of bioactive substances enantiomers (RFBR, 2013-2014)
  6. The chromatographic separation of optic isomers under overloading column conditions (RFBR, 2010-2012)

Achievements and Recognitions:

  • Young Scientist Scholarship from the Russian Science Support Foundation (2009-2010)
  • Pavel Solov’ev Medal and Award from Perm Region Government (2014) for her work on isolating enantiomerically pure drug forms by chromatographic separation of optical isomers

Publications and Citations:

Elena has an extensive list of publications in high-impact journals, focusing on chromatographic enantioseparation and adsorption thermodynamics. Some notable publications include:

  1. Retention mechanisms of dipeptides on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases. Journal of Chromatography A, 2024.
  2. Chiral zwitterionic stationary phases based on Cinchona alkaloids and dipeptides: Application in chiral separation of dipeptides under reversed phase conditions. Journal of Chromatography A, 2024.
  3. Retention mechanisms of rasagiline and its analogues on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases. Journal of Chromatography A, 2023.

Areas of Research:

  • High-performance liquid chromatography on chiral stationary phases
  • Enantioseparations of chiral drugs and biologically active compounds
  • Development of analytical HPLC methods
  • Theory of adsorption and chromatographic analysis

Professional Memberships:

Elena is an active member of several professional organizations and collaborates on various grants, contributing significantly to the field of chemistry and material sciences.

Contributions to Science:
Elena’s research on the chromatographic behavior of new chiral stationary phases has advanced the understanding of enantiorecognition and retention mechanisms. Her theoretical models have provided valuable insights into the interaction of solvents and analytes, aiding the development of effective separation techniques for stereoisomers.

🎓Publication Top Noted:

Paper Title : Enantioselective chromatography of dipeptides on adsorbents with grafted antibiotics

  • Authors: Elena Reshetova
  • Journal: Conference abstract at Mendeleev Congress
  • Year: 2024
Paper Title : Chiral zwitterionic stationary phases based on Cinchona alkaloids and dipeptides: Application in chiral separation of dipeptides under reversed phase conditions
    • Authors: Leonid D. Asnin, Daria I. Ziganshina, Yana A. Klimova, Elena N. Reshetova, Jiří Tůma, Michal Kohout
    • Journal: Journal of Chromatography A
    • Year: 2024
Paper Title : Retention mechanisms of dipeptides on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases
  • Authors: Elena N. Reshetova, Anna S. Barashkova, Bulat F. Garifullin
  • Journal:Journal of Chromatography A
  • Year: 2024
Paper Title :Enantioselective chromatography of amines and dipeptides on superficially porous particle adsorbents with grafted teicoplanin and vancomycin antibiotics
  • Authors: Elena Reshetova
  • Journal:Conference abstract at All-Russian symposium with international participation “Physico-chemical problems of adsorption, structure and surface chemistry of nanoporous materials
  • Year: 2023

Paper Title :Retention mechanisms of rasagiline and its analogues on superficially porous particle vancomycin- and teicoplanin-based chiral stationary phases

  • Authors: Elena Reshetova, Leonid Asnin
  • Journal:Journal of Chromatography A
  • Year: 2023